Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial

被引：0
|
作者：
Matsuyuki Doi
Kiyoshi Morita
Junzo Takeda
Atsuhiro Sakamoto
Michiaki Yamakage
Toshiyasu Suzuki
机构：
[1] Hamamatsu University Hospital,Department of Anesthesiology and Intensive Care
[2] Okayama University,Department of Anesthesiology
[3] Keio University,Department of Anesthesiology
[4] Nippon Medical School,Department of Anesthesiology
[5] Sapporo Medical University School of Medicine,undefined
[6] Tokai University of Medicine,undefined
来源：
Journal of Anesthesia | 2020年 / 34卷
关键词：
Remimazolam; General anesthesia; Phase 3; Propofol; CNS7056; ONO-2745;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：543 / 553
页数：10
相关论文
共 50 条
  • [21] Correction to: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
    Xiaoqiang Zhang
    Shuang Li
    Jing Liu
    BMC Anesthesiology, 21
  • [22] The safety and efficacy of remimazolam tosylate combined with propofol in upper gastrointestinal endoscopy: A multicenter, randomized clinical trial
    Wei, Ai
    Ma, Shijin
    Dou, Yuzhe
    Wang, Xiaojun
    Wu, Jianxiong
    Zhou, Shuzhi
    Deng, Yanfang
    Liu, Xinquan
    Li, Dongming
    Yang, Mengchang
    PLOS ONE, 2023, 18 (08):
  • [23] Comparing the efficacy and safety of three surgical approaches for total hysterectomy (TSATH): protocol for a multicentre, single-blind, parallel-group, randomised controlled trial
    Zhang, Wenxi
    Deng, Li
    Yang, Fan
    Liu, Jianhong
    Chen, Sijing
    You, Xiaolin
    Gou, Jiani
    Zi, Dan
    Li, Yonghong
    Qi, Xiaoxue
    Wang, Yanzhou
    Zheng, Ying
    BMJ OPEN, 2024, 14 (01):
  • [24] Efficacy and Safety of Solifenacin Succinate 10 mg Once Daily: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients With Overactive Bladder
    Chu, Franklin
    Smith, Neila
    Uchida, Takeshi
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2009, 70 (06): : 405 - 420
  • [25] Comparative Efficacy and Safety of Anterograde vs. Retrograde Iodine Staining During Esophageal Chromoendoscopy: A Single-Center, Prospective, Parallel-Group, Randomized, Controlled, Single-Blind Trial
    Tian, Xu
    Yang, Wei
    Chen, Wei-Qing
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial
    Asadollahi, Shadi
    Heidari, Kamran
    Hatamabadi, Hamidreza
    Vafaee, Reza
    Yunesian, Somayeh
    Azadbakht, Alireza
    Mirmohseni, Ladan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (03) : 142 - 150
  • [27] Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
    Okubo, Kimihiro
    Gotoh, Minoru
    Asako, Mikiya
    Nomura, Yasuyuki
    Togawa, Michinori
    Saito, Akihiro
    Honda, Takayuki
    Ohashi, Yoshihiro
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 97 - 105
  • [28] Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease:: results of a randomized, double-blind, parallel-group multicenter study
    Gutzmann, H
    Kühl, KP
    Hadler, D
    Rapp, MA
    PHARMACOPSYCHIATRY, 2002, 35 (01) : 12 - 18
  • [29] EFFICACY AND SAFETY OF CELECOXIB COMPARED WITH PLACEBO AND ETODOLAC FOR ACUTE POSTOPERATIVE PAIN: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, CONTROLLED TRIAL
    Ishiguro, Naoki
    Hanaoka, Akio
    Okada, Toshiyuki
    Ito, Masanori
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (1-2): : 81 - 93
  • [30] Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials
    Sayasone, Somphou
    Odermatt, Peter
    Vonghachack, Youthanavanh
    Xayavong, Syda
    Senggnam, Kanpaseuth
    Duthaler, Urs
    Akkhavong, Kongsap
    Hattendorf, Jan
    Keiser, Jennifer
    LANCET INFECTIOUS DISEASES, 2016, 16 (10): : 1145 - 1153
12345